By: Jiao Tong
Abstract In this real-world study, 153 adult T-cell lymphoblastic lymphoma (T-LBL) patients from sixteen centers in Shanghai were enrolled.
Jiao Tong is a prolific writer and journalist whose work has appeared in various prestigious publications such as Nature Portfolio, Cell Press, and Frontiers. With a focus on scientific research and advancements, Jiao's articles cover a wide range of topics including biomedicine, nanotechnology, machine learning, and cancer therapy. Their expertise in bioinformatics and their ability to analyze complex scientific data make them a valuable contributor to the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Jiao Tong's coverage is heavily focused on scientific and healthcare topics, with a significant emphasis on citing data. To effectively reach out to Jiao, consider providing access to reliable and relevant data that supports the topic being discussed. Additionally, as Jiao covers a wide range of scientific themes such as polymer science, biomedicine, medical research, physics, and engineering; ensure pitches are tailored to these specific areas.
Given the technical nature of the articles covered by Jiao Tong and their focus on scientific data-driven insights in healthcare & pharmaceuticals fields along with industry-specific content like polymer science or medical research it would be beneficial for outreach efforts targeting her to involve experts who can provide detailed analysis or commentary supported by robust scientific evidence.
This information evolves through artificial intelligence and human feedback. Improve this profile .